The real-world safety profile of sodium-glucose co-transporter-2 inhibitors among older adults (≥ 75 years): a retrospective, pharmacovigilance study

BACKGROUND: As indications for sodium-glucose co-transporter-2 inhibitors (SGLT2i) are expanding, a growing number of older adults have become candidates for treatment. We studied the safety profile of SGLT2i among older adults. METHODS: A retrospective, pharmacovigilance study of the FDA’s global d...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldman, Adam, Fishman, Boris, Twig, Gilad, Raschi, Emanuel, Cukierman-Yaffe, Tali, moshkovits, Yonatan, Pomerantz, Alon, Ben-Zvi, Ilan, Dankner, Rachel, Maor, Elad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875397/
https://www.ncbi.nlm.nih.gov/pubmed/36694178
http://dx.doi.org/10.1186/s12933-023-01743-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875397/
https://www.ncbi.nlm.nih.gov/pubmed/36694178
http://dx.doi.org/10.1186/s12933-023-01743-5

Ejemplares similares